- Abstract Number: 1119
Treatment Outcomes of TNF-α Inhibitors in Cardiac Sarcoidosis
- Abstract Number: 0345
Treatment Patterns and Glucocorticoid Burden of Dermatomyositis Patients: A Cohort Study in the University of Pittsburgh’s Myositis Registry
- Abstract Number: 0663
Treatment Patterns and the Prevalence of Kidney Biopsy-Confirmed LN in Patients with SLE and Proteinuria: A Multicenter Cohort Study
- Abstract Number: 1454
Treatment Patterns, Clinical Characteristics, and Patient-Reported Outcomes Among Patients with Axial Spondyloarthritis Treated in Real-World Rheumatology Practices in the US
- Abstract Number: 1691
Treatment Response Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease
- Abstract Number: 2231
Treatment Response over the First 6 Months in Newly Diagosed RA Patients by Pain, Anxiety, Depression & Fatigue (PADF) Symptom Clusters: Results from the Canadian Early Arthritis Cohort
- Abstract Number: 1845
Treg Expansion and IL-6 Induced STAT3 Phosphorylation in CD4+ T Cells Is a Biomarker of Disease Flare in Rheumatoid Arthritis
- Abstract Number: 1523
Trend Analysis of Lupus Nephritis Flares, Mortality, and Disparities: 2016-2020
- Abstract Number: 0998
Trends and Disparities in Cardiovascular Deaths in Systemic Lupus Erythematosus: A Population-Based Retrospective Study in the United States from 1999 to 2021
- Abstract Number: 2621
Trends in Disease Activity in Rheumatoid Arthritis over 2009-2023 Utilizing DAS28-CRP Inferred from Electronic Health Records
- Abstract Number: 2421
Trends in Glucocorticoid Use in Systemic Lupus Erythematosus in a Population-Based Inception Cohort from 1976 to 2018: The Lupus Midwest Network
- Abstract Number: 0509
Trends in Initiation of Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Among Commercially-Insured US Adults, 2001-2021
- Abstract Number: 0280
Trends in Management and Consultations for Gout: A Study of 18 Million Adults Using the OpenSAFELY Platform
- Abstract Number: 0397
Trends in New Use of Disease-Modifying Antirheumatic Drugs in Juvenile Idiopathic Arthritis Among Commercially Insured Children in the United States from 2001-2022
- Abstract Number: 1877
Trends in Rheumatoid Arthritis Incidence, Prevalence, DALY and Death Rates (1991-2021) in the United States: A Comprehensive Analysis of State-Level Disparities
- « Previous Page
- 1
- …
- 168
- 169
- 170
- 171
- 172
- …
- 181
- Next Page »